Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes

You may not qualify if:

• uses injected medications (e.g., insulin, exenatide) for glucose control.
• history of diabetic ketoacidosis
• current infection ; inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks
• active malignancy
• states he/she has had a significant cardiovascular event \< 12 weeks prior to study entry or history of congestive heart failure in the last 12 months.
• end stage organ failure
• active metabolic, hepatic, or gastrointestinal disease that may interfere with nutrient absorption, distribution, metabolism, or excretion (such as gastroparesis), excluding diabetes.
• chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
• use of herbals, dietary supplements, or medications, other than allowed medications, during past four weeks that could profoundly affect blood glucose.
• symptomatic in response to blood collection prior to enrollment into this study.
• clotting or bleeding disorders.
• non-typical eating pattern
• is currently using diabetes-specific nutritional product(s)defined as more than one eating occasion per week.
• engages in strenuous exercise five or more times per week.